申请人:Oncopeptides AB
公开号:US20210388024A1
公开(公告)日:2021-12-16
The invention provides a compound of formula (I), or a pharmaceutically acceptable salt thereof (Formula I), wherein, each R
1
—R
30
is independently selected from the group consisting of H and deuterium, and at least one of R
1
—R
30
is deuterium with an abundance level greater than the naturally occurring abundance of deuterium. The invention also provides pharmaceutical compositions containing the compounds, and uses of the compounds.